Preclinical Evaluation of the Novel Small-Molecule MSI-N1014 for Treating Drug-Resistant Colon Cancer via the LGR5/β-catenin/miR-142-3p Network and Reducing Cancer-Associated Fibroblast Transformation
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Preclinical Evaluation of the Novel Small-Molecule MSI-N1014 for Treating Drug-Resistant Colon Cancer via the LGR5/β-catenin/miR-142-3p Network and Reducing Cancer-Associated Fibroblast Transformation
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 6, Pages 1590
Publisher
MDPI AG
Online
2020-06-17
DOI
10.3390/cancers12061590
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Biological heterogeneity and versatility of cancer-associated fibroblasts in the tumor microenvironment
- (2019) Luke Bu et al. ONCOGENE
- Serum level of miR-142-3p predicts prognostic outcome for colorectal cancer following curative resection
- (2019) Wencang Gao et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Increased expression of cancer-associated fibroblast markers at the invasive front and its association with tumor-stroma ratio in colorectal cancer
- (2019) Tessa P. Sandberg et al. BMC CANCER
- Insluin and epithelial growth factor (EGF) promote programmed death ligand 1(PD-L1) production and transport in colon cancer stem cells
- (2019) Mingshui Chen et al. BMC CANCER
- Cancer-associated fibroblasts induce epithelial–mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling
- (2019) Cassandra Ringuette Goulet et al. BMC CANCER
- miR-142-3p suppresses uveal melanoma by targeting CDC25C, TGFβR1, GNAQ, WASL, and RAC1
- (2019) Dewei Peng et al. Cancer Management and Research
- Regulatory T Cells Promote Overexpression of Lgr5 on Gastric Cancer Cells via TGF-beta1 and Confer Poor Prognosis in Gastric Cancer
- (2019) Xiao-Sun Liu et al. Frontiers in Immunology
- MiR‐142‐3p functions as a tumor suppressor by targeting RAC1/PAK1 pathway in breast cancer
- (2019) Tao Xu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5‐Fluorouracil, and Leucovorin Versus Oxaliplatin, 5‐Fluorouracil, Leucovorin, and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Preoperative Chemoradiation: A Trial of the ECOG‐ACRIN Research Group (E5204)
- (2019) A. Bapsi Chakravarthy et al. ONCOLOGIST
- miR-142-3p attenuates breast cancer stem cell characteristics and decreases radioresistance in vitro
- (2018) Fabian M Troschel et al. TUMOR BIOLOGY
- Mesenchymal Cells in Colon Cancer
- (2017) Vasiliki Koliaraki et al. GASTROENTEROLOGY
- Targeted blockade of TGF-β and IL-6/JAK2/STAT3 pathways inhibits lung cancer growth promoted by bone marrow-derived myofibroblasts
- (2017) Jindong Shi et al. Scientific Reports
- Efficacy and safety of bevacizumab plus chemotherapy compared to chemotherapy alone in previously untreated advanced or metastatic colorectal cancer: a systematic review and meta-analysis
- (2016) Tobias Engel Ayer Botrel et al. BMC CANCER
- Full-length LGR5-positive cells have chemoresistant characteristics in colorectal cancer
- (2016) Hideki Osawa et al. BRITISH JOURNAL OF CANCER
- Carcinoma-associated fibroblasts affect sensitivity to oxaliplatin and 5FU in colorectal cancer cells
- (2016) Samuel Gonçalves-Ribeiro et al. Oncotarget
- What Do We Learn from Spheroid Culture Systems? Insights from Tumorspheres Derived from Primary Colon Cancer Tissue
- (2016) Komal Qureshi-Baig et al. PLoS One
- Structure-based hybridization, synthesis and biological evaluation of novel tetracyclic heterocyclic azathioxanthone analogues as potential antitumor agents
- (2015) Tsung-Chih Chen et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- CD90+stromal cells are the major source of IL-6, which supports cancer stem-like cells and inflammation in colorectal cancer
- (2015) Phuong T. Huynh et al. INTERNATIONAL JOURNAL OF CANCER
- 5-Fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) plus sunitinib or bevacizumab as first-line treatment for metastatic colorectal cancer: a randomized Phase IIb study
- (2015) J. Randolph Hecht et al. Cancer Management and Research
- Direct Interaction between Carcinoma Cells and Cancer Associated Fibroblasts for the Regulation of Cancer Invasion
- (2015) Hideki Yamaguchi et al. Cancers
- β1, 4-N-acetylgalactosaminyltransferase III modulates cancer stemness through EGFR signaling pathway in colon cancer cells
- (2015) Mei-Ieng Che et al. Oncotarget
- Isolation of colorectal cancer stem-like cells
- (2014) Eunice Dotse et al. CYTOTECHNOLOGY
- The R-spondin/Lgr5/Rnf43 module: regulator of Wnt signal strength
- (2014) W. de Lau et al. GENES & DEVELOPMENT
- TWIST1 and SNAI1 as markers of poor prognosis in human colorectal cancer are associated with the expression of ALDH1 and TGF-β1
- (2014) YONG HUN KIM et al. ONCOLOGY REPORTS
- Trifluoperazine, an Antipsychotic Agent, Inhibits Cancer Stem Cell Growth and Overcomes Drug Resistance of Lung Cancer
- (2012) Chi-Tai Yeh et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Cancer-Associated Fibroblasts Drive the Progression of Metastasis through both Paracrine and Mechanical Pressure on Cancer Tissue
- (2012) G. S. Karagiannis et al. MOLECULAR CANCER RESEARCH
- LGR4 and LGR5 are R-spondin receptors mediating Wnt/β-catenin and Wnt/PCP signalling
- (2011) Andrei Glinka et al. EMBO REPORTS
- Smad4-Mediated Signaling Inhibits Intestinal Neoplasia by Inhibiting Expression of β-Catenin
- (2011) Tanner J. Freeman et al. GASTROENTEROLOGY
- Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling
- (2011) Wim de Lau et al. NATURE
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- Oncogenic mutations as predictive factors in colorectal cancer
- (2010) A Lièvre et al. ONCOGENE
- Experimentally Derived Metastasis Gene Expression Profile Predicts Recurrence and Death in Patients With Colon Cancer
- (2009) J. Joshua Smith et al. GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started